Biotech Analyst Watsek discusses upcoming readouts of Immunotherapy in Gastric/GEJ/EAC Adenocarcinoma Cancers (relevant companies ALXO, RCUS and ZYME) on an Analyst/Industry conference call to be held on September 13 at 11 am. Webcast Link
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on ALXO:
- Cantor Fitzgerald biotech analyst to hold an analyst/industry conference call
- ALX Oncology appoints Jason Lettmann as CEO
- ALX Oncology Realigns Executive Leadership Team
- ALX Oncology risk/reward ‘compelling’ into data, say Piper Sandler
- ALX Oncology files to sell 18.45M shares of common stock for holders
